[Form 3] BAXTER INTERNATIONAL INC Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Baxter International Inc. executive James Teaff filed an initial Form 3 reporting his ownership of company securities. He reports direct ownership of 31,120 shares of Baxter common stock. The filing also lists several stock option awards, each giving the right to buy Baxter common shares at set exercise prices before future expiration dates.
These options cover blocks of shares at exercise prices ranging from $20.37 to $85.23 per share, with expiration dates between 2027 and 2036. Footnotes explain that the options generally become exercisable in three equal annual installments starting on the first anniversary of their respective grant dates. The filing records current holdings and does not reflect new open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Teaff James
Role
President, CCS
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock, $1 par value | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,011 shares (Direct);
Common Stock, $1 par value — 31,120 shares (Direct)
Footnotes (1)
- The options became exercisable in three equal annual installments beginning on March 5, 2018, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 4, 2019, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on February 28, 2020, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 22, 2021, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. The options became exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Key Figures
Direct common shares: 31,120 shares
Option at $50.77: 4,011 underlying shares at $50.77
Option at $66.31: 3,436 underlying shares at $66.31
+5 more
8 metrics
Direct common shares
31,120 shares
Common Stock, $1 par value, direct ownership
Option at $50.77
4,011 underlying shares at $50.77
Stock Option (Right to Buy), expiration 2027-03-02
Option at $66.31
3,436 underlying shares at $66.31
Stock Option (Right to Buy), expiration 2028-03-01
Option at $74.73
3,018 underlying shares at $74.73
Stock Option (Right to Buy), expiration 2029-02-28
Option at $77.15
5,544 underlying shares at $77.15
Stock Option (Right to Buy), expiration 2031-03-03
Option at $85.23
3,101 underlying shares at $85.23
Stock Option (Right to Buy), expiration 2032-03-02
Option at $39.06
6,333 underlying shares at $39.06
Stock Option (Right to Buy), expiration 2033-03-01
Option at $20.37
25,862 underlying shares at $20.37
Stock Option (Right to Buy), expiration 2036-02-27
Key Terms
Stock Option (Right to Buy), Common Stock, $1 par value, exercisable in three equal annual installments, grant date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Common Stock, $1 par value financial
"underlying_security_title: "Common Stock, $1 par value""
exercisable in three equal annual installments financial
"The options became exercisable in three equal annual installments..."
grant date financial
"beginning on March 5, 2018, the first anniversary of the grant date."
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
exercise price financial
"conversion_or_exercise_price: "20.3700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
